Related Experiment Video

Updated: Jul 9, 2026

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
09:53

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus

Published on: August 25, 2017

Kaposi sarcoma: appraisal of therapeutic agents

Liron Pantanowitz

    Cancer
    |December 22, 2007
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
    07:02

    Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)

    Published on: September 14, 2010

    Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus
    07:10

    Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus

    Published on: August 15, 2025

    Related Experiment Videos

    Last Updated: Jul 9, 2026

    An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
    09:53

    An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus

    Published on: August 25, 2017

    Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
    07:02

    Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)

    Published on: September 14, 2010

    Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus
    07:10

    Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus

    Published on: August 15, 2025

    Related Concept Videos

    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

    Articles linked to this work by shared authors, journal, and citation graph.

    Molecular Characterization of Thyroid Follicular Lesions in the Era of "Next-Generation" Techniques.

    Frontiers in endocrinology·2022

    Characterization of SARS-CoV-2 and host entry factors distribution in a COVID-19 autopsy series.

    Communications medicine·2022

    PD-L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedside.

    Clinical and experimental dental research·2022

    Cytomorphology of nodular histiocytic/mesothelial hyperplasia.

    Diagnostic cytopathology·2022

    Serous fluid: Metastatic sarcomas, melanoma, and other non-epithelial neoplasms.

    CytoJournal·2022

    Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer.

    BMC cancer·2022

    Prevalence of breast, cervical, and colorectal cancer screening among adults according to disability type and difficulty level, United States, 2021 and 2023.

    Cancer·2026

    Elevated risk of ischemic stroke after invasive cancer diagnosis: A nationwide population-based study.

    Cancer·2026

    Long-term outcomes and patterns of failure in patients with thymic malignancies treated with surgery and radiation therapy.

    Cancer·2026

    GPRC5D-targeting bispecific and trispecific antibodies in multiple myeloma: Current evidence and emerging strategies.

    Cancer·2026

    Adjuvant CDK4/6 inhibitors in early-stage breast cancer: Clinical evidence and considerations for risk stratification and treatment selection.

    Cancer·2026

    The burden of male breast cancer (MBC) in the GBD Central, Eastern, and Western Europe Regions from 1990 to 2023: Results from the Global Burden of Disease Study 2023.

    Cancer·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us